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ABSTRACT
Loss of function of the RNA helicase maleless (MLE)
in Drosophila melanogaster leads to male-specific
lethality due to a failure of X chromosome dosage
compensation. MLE is presumably involved in
incorporating the non-coding roX RNA into the
dosage compensation complex (DCC), which is an
essential but poorly understood requirement for
faithful targeting of the complex to the X chromo-
some. Sequence comparison predicts several RNA-
binding domains in MLE but their properties have
not been experimentally verified. We evaluated the
RNA-binding characteristics of these conserved
motifs and their contributions to RNA-stimulated
ATPase activity, to helicase activity, as well as to the
targeting of MLE to the nucleus and to the X
chromosome territory. We find that RB2 is the
dominant, conditional RNA-binding module, which
is indispensable for ATPase and helicase activity
whereas the N-terminal RB1 motif does not bind
RNA, but is involved in targeting MLE to the X
chromosome. The C-terminal domain containing a
glycine-rich heptad repeat adds potential dimeriza-
tion and RNA-binding surfaces which are not
required for helicase activity.
INTRODUCTION
The gene that encodes the RNA helicase maleless (MLE)
wasoriginally discoveredinascreen formale-speciﬁc lethal
mutations that revealed genes crucial for dosage compen-
sation in male Drosophila melanogaster (1). This system
serves to increase the transcription from the single X
chromosome in male fruit ﬂies to match the cumulative
expression from the two female X chromosomes (2–4).
Failure of this activation of transcription in the 2-fold
rangeislethalformaleﬂies.ThefunctionofMLEindosage
compensation is not known but it is presumably involved
in mediating the eﬀects of two non-coding roX (RNA-
on-the-X) RNAs, roX1 and roX2, which are obligatory for
dosage compensation. These two RNAs reside in a regul-
atory ribonucleoprotein complex, the dosage compensa-
tion complex (DCC; also known as Male-speciﬁc lethal or
MSLcomplex).TheDCC presumablyﬁrstassemblesatthe
site of roX transcription, from which it distributes to
associate with many sites on the X chromosome, most
prominently the coding regions of target genes (5,6). In the
absence of roX the MSL proteins will only bind to a
reduced number of sites on the X chromosome (7).
So far, three proteins of the DCC are known to interact
with RNA: the histone acetyltransferase MOF (8), male-
speciﬁc lethal-3 (MSL3) (9,10) and MLE (1,11,12). Since
MLE is maternally provided to the Drosophila egg, it is the
ﬁrst protein to interact with and to stabilize the roX1
RNA, which is transcribed 2h after egg laying (13). In the
absence of MLE, roX RNA is not incorporated into the
DCC and can only be seen at the site of transcription in
polytene chromosomes (14). The ATPase/helicase activity
of MLE is required for its function in dosage compensa-
tion (11,15). Recently, Lucchesi and colleagues generated
mutations in MLE that separate ATPase and helicase
activities and found that the ATPase activity was suﬃcient
for MLE’s role in transcriptional activation, whereas
the helicase activity is necessary for the spreading of the
complex along the X chromosome (16). roX RNA may
play a transient role in targeting the DCC to the X
chromosome (17), which suggests that its interaction
with the complex is dynamic. Accordingly, MLE is not
an integral member of the DCC, but peripherally
associated, which leads to its loss during puriﬁcation of
the complex (18,19).
Although it is usually assumed that roX RNAs are
the crucial targets of MLE, this has not been conﬁrmed.
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are not reﬂected by the male-speciﬁc lethal phenotype of
its loss-of-function mutant. One particular temperature
sensitive (ts) MLE allele, MLE
napts (nap stands for ‘no
action potential’), is characterized by a reduced expression
of the para gene, which encodes a Na
+ channel of the
nervous system (20). The data are consistent with the idea
that the MLE helicase activity is required to unwind a
secondary structure of the para primary transcript to
permit faithful splicing. Other possibilities should not be
excluded since RNA helicase A (RHA) (12,21), the MLE
ortholog in vertebrates, has been implicated in various
aspects of RNA metabolism, including transcription,
processing and translation (22). Most recently, RHA
was shown to be involved in the loading of small
interfering RNAs (siRNA) into RISC (RNA-induced
silencing complex) (23). Following the idea that dosage
compensation mechanisms adapt components of other
nuclear processes to ﬁne-tuning chromatin structure (3)
leads to speculations that MLE activity may aﬀect the
secondary structure of roX RNAs to facilitate productive
interactions with the MSL proteins.
Currently, all our knowledge about MLE as an enzyme
stems from the pioneering study of Lee et al. (11) who
documented that recombinant MLE has ATPase and
helicase activities and binds single-stranded nucleic acids.
In the current work we extended the biochemical analysis
signiﬁcantly, by subjecting MLE to a thorough structure-
function analysis, which clariﬁed the domain requirements
for RNA interaction, helicase activity and localization to
the X chromosomal territory. In addition we analyzed the
eﬀects of nucleotides on RNA-binding as a ﬁrst step
towards a mechanistic understanding of the nucleotide
cycle of MLE’s helicase activity.
MATERIALS AND METHODS
Monoclonal anti-MLE antibodies
The NcoI/HindIII DNA fragment, corresponding to
the ﬁrst 265 amino acids (aa) of MLE was cloned
from the pBB-6X-HisMLE (a gift from M. Kuroda) into
the pGEX-2KG expression vector (Amersham). This
construct was used to express and purify GST-MLE
1–265
from Escherichia coli BL21 using standard conditions.
Monoclonal antibodies were raised and MLE
1–265 speciﬁc
antibodies were screened by ELISA. Hybridoma 6E11 was
subcloned to obtain monoclonal antibodies.
Expression andpurification of proteins from Sf9 cells
Sf9 cells were kept at 268C in Sf-900 II medium
(Invitrogen) supplemented with penicillin and streptomy-
cin. Recombinant baculoviruses expressing MLE deriva-
tives were produced using the Bac-to-Bac expression
system (Invitrogen). MLE full length was expressed with
a C-terminal ﬂag-tag or with an N-terminal His6-tag.
MLE deletion mutants were all C-terminally ﬂag-tagged.
The RB1, RB2 and RB1-2 domains were expressed with
an N-terminal His6-tag, whereas the G-domain was ﬂag-
tagged at the C-terminus.
Sf9 cells were infected under standard conditions and
the optimal amount of each virus was determined
empirically. The cells ( 3 10
7) were collected 2 days
post infection and lysed in 1ml lysis buﬀer [50mM Hepes
pH 7.6, 0.3M KCl, 0.5mM EDTA, 0.1% NP40, 1mM
DTT, protease inhibitors (PMSF, leupeptine, aprotinin,
pepstatin) and incubated for 15min on ice. The suspension
was sonicated by three pulses of 15sec at 15% amplitude
(Branson digital soniﬁer model 250-D), and centrifuged
for 30min at 14k.r.p.m. at 48C. Supernatants were
incubated for 2h on a rotating wheel with anti-ﬂag M2
(Sigma) aﬃnity beads (50ml of a 1:1 slurry in lysis buﬀer).
The beads were washed ﬁve times with 1ml of each of the
three following buﬀers: Buﬀer I: 0.3M KCl, 50mM Hepes
pH 7.6, 0.5mM EDTA, 1% NP40, 0.5mM DTT, protease
inhibitors; Buﬀer II: Buﬀer I with 1M KCl; Buﬀer III:
0.15M KCl, 10mM Hepes pH 7.6, 0.5mM EDTA, 0.1%
NP40, 10% glycerol, 0.5mM DTT, protease inhibitors.
Proteins were eluted (two times for 2h on a rotating
wheel at 48C) in 100ml of Buﬀer III supplemented with
5–10mg/ml ﬂag peptide. Aliquots of the eluted proteins
were analyzed by SDS-PAGE and Coomassie staining and
the remainder was stored at  808C.
Pull down experiments
To study MLE dimerization in vitro, Sf9 cells were
coinfected with a virus expressing His6-MLE in combina-
tion with ﬂag-tagged MLE derivatives. Total extracts were
prepared and diluted to 0.15M KCl before incubation
with anti-ﬂag M2 aﬃnity beads for 2h at 48C. Beads were
then washed ﬁve times with 1ml of Lysis Buﬀer (0.15M
KCl) and bound proteins were analyzed by SDS-PAGE
and western-blot.
Glycerol gradient
A 5–16% (w/v) glycerol gradient was prepared in a buﬀer
containing 50mM Hepes pH 7.6, 0.3M KCl, 0.5mM
EDTA, 0.1% NP40, 1mM DTT and protease inhibitors,
using a Gradient Master 105/106 (BioComp) set at
2.40min/81.5deg/15r.p.m. A 500ml sample containing
15mg of MLE-ﬂag puriﬁed from Sf9 cells and 10mgo f
aldolase and catalase standard markers (Amersham) was
loaded on top of the gradient. Centrifugation was
performed using a SW41 rotor (Beckman) at 35k.r.p.m.
for 20h at 48C. Fractions of 0.5ml were collected and
analyzed by 8% SDS-PAGE and western blot.
Preparation ofRNA substrates
The SP6.roX2 reverse primer (50CGATTTAGGTGAC
ACTATAGAAATA-TTTG-CTTAATTTGC30), contain-
ing a SP6 promoter and the T7.roX2 forward primer
(CGTTAATACGACTCACTATAGGGAGA-CGTG-T
AAAA-TGTT-30), containing a T7 promoter were used to
amplify a 75bp roX2 DNA sequence, predicted not to
form double strand RNA structures (RNA fold program;
http://rna.tbiunivie.ac.at/cgi-bin/RNAfold.cgi) using a
roX2.78.2.2 cDNA) template (a gift from Kuroda M.).
The PCR product was puriﬁed on MinElute Spin
Columns (Qiagen). 1mg of the PCR product was
transcribed in vitro in the presence of ATP, GTP, UTP
Nucleic Acids Research,2008, Vol. 36,No. 3 951(2.5mM each), CTP (100mM) supplemented with a
32P-
CTP, 1mM DTT, 1ml of T7 RNA Polymerase (Promega),
1 U/ml RNAsin (Promega) and 1 transcription buﬀer
(Promega) in 25ml of ﬁnal volume. The reaction mixture
was incubated at 378C for 2h and the radiolabeled ssRNA
was puriﬁed on miniQuickSpin RNA columns (Roche)
and obtained in 100ml of DEPC-treated water. The RNA
concentration was measured spectrophotometricaly. In
most cases, the speciﬁc activity of the labeled ssRNA
substrate was 10
2 cpm/fmole. The dsRNA substrate was
prepared by annealing the radiolabeled ssRNA with the
corresponding cold complementary ssRNA transcribed
from the same PCR product with SP6 RNA Polymerase.
The resulting partial RNA duplex molecule consisted of
40bp dsRNA ﬂanked by 18bp and 19bp ssRNA
30overhanging sequences in the top and the bottom
strand, respectively (Figure 1B). The annealing reaction
(200ml) containing equimolar amounts of the radioactive
A 
1 
RB2  RB1 
69 170  240  382  569 667 773 
helicase  ATPase 
RB1  RB2 
340 
RB1-2 
his 
RB1 
121 
RB1 
his 
RB2 
340 
122 
RB2 
his 
1193  1271 
1289 
MLE 
flag 
G 
1163  G 
flag 
G 
30 
15 
20 
40 
RB1 G  M  RB1-2 RB2 
T7/Sp6
transcription
dsRNA
5′ 3′ ssRNA
3′ 5′
3′
roX2 T7
Sp6
5′
B
D
dsRNA
(pmoles)
dsRNA
complexes
RB1 RB2 RB1-2
24 12 4 12 4 12 4 1
ssRNA
ssRNA
ssRNA
complexes
G
ss    ds
C
%
 
 
d
s
R
N
A
 
b
i
n
d
i
n
g
protein (pmol)
0
10
20
15
5
1 5 4 3 2
25
30
0
RB1
RB2
RB1-2
G
Figure 1. Predicted RNA-binding domains in MLE. (A) Schematic representation of the predicted features of MLE and of the expressed fragments
containing individual domains that were analyzed for RNA-binding. All proteins were tagged, either with a C-terminal ﬂag-tag or an N-terminal
His6-tag (black bars). The numbers represent the MLE aa that delineate the domains. Insert: The puriﬁed recombinant MLE derivatives were
separated by polyacrylamide gel electrophoresis (PAGE) and stained with Coomassie Blue. Lane M displays a size marker with indicated molecular
weights in kDa. (B) Scheme of the ssRNA and dsRNA substrates. The sequence of roX2 is depicted in black, Sp6 promoter and T7 promoter are
shown in grey. (C) Electrophoretic mobility shift assay (EMSA). The indicated amounts of the predicted RNA-binding domains (1–4pmoles/
50–200nM) were incubated on ice in the presence of 25fmol (1.25nM) radiolabeled dsRNA or ssRNA. RNA–protein complexes (bracketed regions)
were resolved on a 1.8% agarose gel and visualized by PhosphoImager analysis of the dried gel. Positions of ssRNA and dsRNA are indicated.
(D) Filter-binding assay. Binding of the predicted RNA-binding domains to dsRNA was analyzed by ﬁlter-binding as described in Materials and
Methods section. Each sample was analyzed in duplicates and error bars reﬂect the experimental variation.
952 Nucleic Acids Research, 2008, Vol. 36, No. 3ssRNA and the cold complementary RNA in hybridiza-
tion buﬀer (20mM HEPES-KOH, pH 7.6, 0.5M NaCl,
1mM EDTA, 0.1% SDS), was incubated 5min at 1008C,
30min at 658C and 4h at room temperature. The dsRNA
was then puriﬁed by electrophoresis on a native 10%
polyacrylamide (30:1) gel in TBE. The gel slice, containing
the dsRNA transcript (located by autoradiography) was
ground with a micropestle and eluted twice in 0.4ml of
elution buﬀer (0.5M ammonium acetate, pH 7, 0.1%
SDS, 10mM EDTA) for 2h at room temperature in a
shaking incubator. After a brief centrifugation the super-
natant was extracted with phenol/chloroform, ethanol
precipitated and resuspended in the appropriate volume of
DEPC-treated water.
ATPase assay
The ATPase activity of MLE-ﬂag (25 fmol, 1.25 nM) and
the corresponding mutant proteins was measured in a
20ml reaction containing 6.6mM HEPES pH 7.6,
0.66mM EDTA, 0.66mM 2-mercaptoethanol, 0.033%
NP40, 1.1mM MgCl2,3 3 mM ATP, 5mCi [g-
32P] ATP
(3000Ci mmol
 1, NEN) in the presence of the indicated
amounts of cold ssRNA or dsRNA. [g-
32P] ATP was
added only after 5min incubation at 268C and 1ml
aliquots were spotted onto PEI thin layer chromatography
plates (Merck) at various time points as previously
described (24). Usually the reaction was linear during
the 20min reaction.
Helicase assay
RNA helicase activity was measured in a 20ml reaction
containing 20mM Hepes-NaOH pH 7.5, 2mM DTT,
3mM MgCl2, 1mM ATP (when indicated), 0.1mg/ml
BSA (NEBiolabs) 1 U/ml RNAsin (Promega), 25fmoles
of dsRNA substrate and the indicated amounts of puriﬁed
proteins for 30min at 378C and then stopped by the
addition of 5mlo f5 Stop Buﬀer (0.1M Tris–Cl pH 7.5,
20mM EDTA, 0.5% SDS, 0.1% NP40, 0.1% bromophe-
nol blue, 0.1% xylene cyanol and 50% glycerol). Aliquots
(10ml) of each reaction were loaded onto a 10%
polyacrylamide (30:1) gel in TBE and electrophoresed at
20mA for 2–3h. RNA was visualized by autoradiography
of the dried gel.
Electrophoretic mobility shiftassay
RNA-binding reaction (20ml) contained radiolabeled
ssRNA or dsRNA (25fmol/1.25nM) in Band-shift
Buﬀer (20mM Hepes-KOH pH 7.6, 3mM MgCl2, 10%
glycerol, 1mM DTT, 0.1mg/ml BSA (NEB)). 1mM ATP,
AMP-PNP, AMP-PCP, ATPgS or ADP were added when
indicated and kept on ice to avoid unwinding. After
incubation for 5min on ice, 10ml of each reaction were
electrophoresed on a 0.8% agarose gel in 0.3 X TBE at
20mA for about 1.5h. Gels were dried and the RNA–
protein complexes visualized by PhosphoImager.
Filter-binding assay
The radiolabeled dsRNA (25fmol) was mixed on ice with
MLE and derivatives in 40ml of Band Shift Buﬀer in the
absence or presence of 1mM of the indicated NTPs. After
5min on ice 15ml of each reaction were ﬁltered in
duplicates through a BA85 Protran nitrocellulose mem-
brane (Schleicher & Schuell) with an underlying nylon
membrane (N+ Amersham) and two sheets of 3MM
Whatman paper under vacuum, using a Dot Blot
apparatus (Schleicher & Schuell). Both membranes and
the sheets of paper were equilibrated for 15min in binding
buﬀer before assembling. The trapped RNA–protein
complexes were washed once with 200ml of binding
buﬀer. The radioactivity retained on both membranes
were quantiﬁed by PhosphoImager and the percentage of
dsRNA retained on the nitrocellulose membrane were
calculated and plotted after subtraction of background
from control samples prepared in the absence of proteins.
Because of the low retention eﬃciency of the nitrocellu-
lose membrane for ssRNA–protein complexes, the ﬁlter-
binding assay was performed only with dsRNA.
Immunofluorescence on SF4
Drosophila SF4 cells were obtained from D. Arndt-Jovin
(MPI for Biophysical Chemistry, Gottingen, Germany).
Cells were kept at 268C in Schneider’s Drosophila medium
(Invitrogen), supplemented with penicillin, streptomycin,
glutamine and 10% fetal calf serum (FCS). The cell
density was maintained below 4 106 cell/ml.
Transient transfections were performed using the
Eﬀectene Reagent Kit (Qiagen), following the manufac-
turer’s instructions. The cells were processed for immuno-
ﬂuorescence as described (25) after 48h of transfection.
Anti-MSL1 antibodies (a gift of M. Kuroda) were used
to mark the X chromosome territory and mouse anti-
GFP antibodies (Molecular Probes) were used to
visualize the fusion proteins. Pictures were taken at
1200 magniﬁcation using a Zeiss AxiopHot microscope
coupled to a Retiga Exi CCD Camera (Qimaging,
Burnaby, Canada). Images were processed using Adobe
Photoshop CS.
RESULTS
RNA-binding domainsof MLE
MLE and its ortholog RHA belong to a group of DExH-
type helicases that are characterized by two doubled-
stranded (ds) RNA-binding (RB) motifs at their N-termini
[Figure 1A, Supplementary Figure 1; (1,21,26)]. In keeping
with their proposed RNA-binding function they are
positively charged at neutral pH, with pIs of 9.6 and
10.0 for RB1 and RB2, respectively. A further feature is a
9-fold imperfect repetition of the sequence GGGYGNN
in the C-terminus of MLE (‘G’ in Figure 1A) (1,12), where
a tyrosine occupies every seventh position within the
repeat (Supplementary Figure 2). Such a pseudo-heptad
arrangement could indicate an amphipatic helix, with a
hydrophobic surface that may be employed in interac-
tions. The C-terminus of MLE (from aa 1163 onwards)
has an overall pI of 11.0 and hence is a strong candidate
for an RNA-binding domain.
In order to experimentally evaluate the RNA-binding
potential of these domains we expressed tagged versions of
Nucleic Acids Research,2008, Vol. 36,No. 3 953RB1, RB2, a fragment consisting of RB1 and RB2, as well
as the glycine-rich C-terminus in insect cells (Figure 1A)
and puriﬁed them to apparent homogeneity using tag
aﬃnity chromatography (Figure 1A, insert). Since any
complex RNA consists of single- (ss) and double-stranded
(ds) RNA segments we characterized the interaction of
the isolated MLE domains with both types of substrates.
Although the RNA substrates we tested were derived
from roX2 RNA the interaction with these substrates
under our conditions was non-speciﬁc [electrophoretic
mobility shift assay (EMSA) data not shown]. In order to
produce a truly ssRNA substrate we ampliﬁed a 75bp
piece of roX2 cDNA which was predicted not to form any
secondary structure when transcribed into RNA (see
Methods section). The PCR product was transcribed
with radiolabeled nucleotide precursors to produce
ssRNA. Annealing of this RNA with unlabeled comple-
mentary RNA, transcribed from the other strand of
the DNA template, yielded a substrate with a dsRNA
core (dsRNA, Figure 1B). The ss and ds RNAs can
be separated by gel electrophoresis (Figures 1C, 2C lanes
‘ss’, ‘ds’) and were used for EMSA. We observed robust
binding of RB2, yielding a continuum of complexes with
ssRNA as well as dsRNA (Figure 1C). Surprisingly, RB1
bound either RNA substrate much worse than RB2. Both
domains together were only slightly more eﬃcient in the
EMSA than RB2 alone, pointing to a very small
contribution of RB1 to RNA interactions in this context.
The G-rich C-terminus proved to be the best binder and
yielded a well-deﬁned complex with both RNA substrates.
In light of the poor RNA interaction of RB1 we were
concerned that EMSA was too stringent to reveal all
RNA interaction potential. We therefore employed ﬁlter-
binding as a second assay. The diﬀerent MLE domains
were allowed to bind radiolabeled dsRNA and the
reactions were then ﬁltered through a nitrocellulose
membrane with an underlying positively charged nylon
membrane. In the absence of protein dsRNA runs through
the nitrocellulose membrane and is retained on the nylon.
Proteins, however, bind to nitrocellulose and trap
associated RNA on this layer of the blot. The percentage
of input dsRNA retained on the nitrocellulose membrane
was calculated and plotted after subtraction of back-
ground from control samples prepared in the absence of
proteins. The ﬁlter-binding assay essentially conﬁrmed the
poor RNA-binding potential of RB1 relative to RB2 and
the C-terminus (Figure 1D).
In order to assess the functions of these domains in the
context of full length MLE we generated a series of MLE
derivatives in which individual domains were deleted
(Figure 2A). These proteins were subjected to the same
RNA-binding assays and showed a much stronger RNA-
binding capacity, since binding is observed at a stoichio-
metry of about 1:1 (as compared to 50–100 fold excess
used for the isolated domains). Binding of intact MLE to
dsRNA yielded two retarded bands, which we interpret as
one and two molecules of MLE interacting with the RNA,
respectively (Figure 2B). Interaction of MLE with ssRNA
led to a clearly deﬁned ssRNA–MLE complex as well as a
smear of retarded bands, conceivably due to heterogeneity
of RNA conformations. Inactivating the ATPase of MLE
by converting lysine 413 to glutamic acid (K413E)
(MLE
GET) led to a slight reduction of dsRNA-binding,
in line with previous observations (11). In agreement with
the poor RNA interaction potential of RB1 (Figure 1),
deletion of the N-terminal RB1 motif did not aﬀect
binding to either substrate (Figure 2B). To our surprise we
found that deleting the G-rich C-terminus improved the
interaction of MLE with dsRNA slightly, but led to a
much better deﬁnition of the MLE–ssRNA complex.
Obviously, although this fragment can interact with RNA
(Figure 1), it does not provide the dominant interaction
surface in the context of MLE in EMSA. Deletion of RB1
was also neutral in the context of the C-terminal
truncation (Supplementary Figure 3). The dominant
RNA recognition motif of the enzyme was revealed by
the deletion of RB2, which essentially abolished all RNA-
binding activity of MLE under those conditions.
When subjected to ﬁlter-binding assay increasing
amounts of MLE and its derivatives led to a concentra-
tion-dependent trapping of RNA on the nitrocellulose
(Figure 2C). Consistent with the EMSA, dsRNA-binding
of GET, RB1 and G derivatives were similar to that of
MLE. In this assay, an MLE derivative lacking the RB2
domain still showed signiﬁcant dsRNA-binding, which
may be due to the C-terminal domain and the central
helicase domain itself, which is known to contact RNA in
the context of other helicases (27). We conclude that
EMSA mainly reveals the strong RNA interaction of RB2,
but other domains, such as the helicase domain and the
C-terminus, contribute to RNA interactions.
Effects ofnucleotides on RNA interactions
Previously, Lee and Hurwitz have analyzed the eﬀect of
ATP on the interactions of MLE with ssRNA and did not
observe a major eﬀect (11). We have now explored how
the presence of ATP, ADP, AMP-PNP, AMP-PCP or the
slow-hydrolyzing derivative ATPgS aﬀect the interaction
of MLE with dsRNA. The incubation of the enzyme
with RNA in the presence of nucleotide was on ice in
order to limit the unwinding of dsRNA in the presence
of ATP. The MLE–RNA complexes were assayed by
EMSA as well as ﬁlter-binding (Figure 3). Under our
conditions some ATP hydrolysis and hence helicase
activity still occurred (Figure 3, upper panel, ATP-
lanes). The corresponding ﬁlter-binding values appear
reduced since MLE binds ssRNA less stably as already
shown in Figure 2.
ATPgS also leads to reduced recovery of MLE–RNA
complexes in the ﬁlter-binding reactions and furthermore
in the EMSA with MLE
RB1 and MLE
G, however, since
this eﬀect is not seen with AMP-PNP and AMP-PCP,
we cannot derive any general conclusion other than
that ATPgS aﬀects the interaction in a particular way.
There is a trend for MLE derivatives to bind RNA better
in the presence of non-hydrolysable ATP analogs.
Conceivably, the RNA interactions are promoted by
ATP-binding. However, MLE also binds RNA well in
the presence of ADP. The MLE
GET mutant is largely
unaﬀected by the presence of nucleotides presumably
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Figure 2. Binding of MLE and MLE derivatives to dsRNA and ssRNA. (A) Schematic representation of MLE deletion constructs analyzed in this
study as in Figure 1A. The insert to the right shows the puriﬁed recombinant MLE derivatives, separated by PAGE and stained with Coomassie
Blue. (B) EMSA as in Figure 1C with protein–RNA complexes (bracketed regions) resolved on a 1.8% agarose gel. Protein amounts range from 6
fmoles (0.3nM) to 50fmoles (2.5nM). (C) dsRNA interactions measured by ﬁlter-binding as in Figure 1D.
Nucleic Acids Research,2008, Vol. 36,No. 3 955because the mutant enzyme binds nucleotides with much
reduced aﬃnity (11).
Effectof theRNA substrate onATPase activity
The ATPase activity of RHA and MLE is strongly
stimulated by RNA, but the eﬀect of ssRNA and dsRNA
have not been compared so far. We also wished to
establish whether any of the domains, besides RB2, was
particularly involved in transmitting the RNA signal to
the ATPase domain. We did not detect signiﬁcant ATPase
activity of MLE
RB2 (data not shown), which is explained
by the fact that RB2 is the major RNA interaction
domain. Deleting the N-terminal RB1 (RB1) or the
C-terminus including the G-rich domain (G) did not
aﬀect the robust, concentration-dependent stimulation of
the ATPase activity by dsRNA (Figure 4A, upper panel).
Interestingly, deletion of the C-terminus selectively
reduced the ATPase stimulation by ssRNA (Figure 4A,
B, lower panels). Combining N- and C-terminal deletions
again did not aﬀect dsRNA stimulation but selectively
reduced the stimulatory eﬀect of ssRNA (Figure 4B).
Analysis of MLE
G thus shows that RNA-binding
(Figure 2) and ATPase stimulation need not necessarily
correlate. A very stable interaction as observed by EMSA
may indicate structural rigidity that does not support
extensive ATPase cycles. Deletion of the C-terminus
renders the enzyme diﬀerentially sensitive towards a
potential helicase substrate (dsRNA) versus the product
of a helicase reaction (ssRNA).
Helicase activity ofmutant enzymes
We next explored how RNA interaction and ATPase
activity are translated into productive helicase activity.
The dsRNA used for EMSA and ATPase stimulation
contains 30 overhangs, which renders it a substrate for the
unwinding reaction of MLE (11). The radiolabeled single
strand that is freed by the unwinding reaction is clearly
separated from the dsRNA on a polyacrylamide gel
(Figure 5). In the absence of ATP no unwinding was
detected (Figure 5A, B, lanes 2–5). Catalytic amounts of
full length MLE eﬃciently unwound the dsRNA substrate
and this process was unaﬀected by deletion of the RB1
domain (Figure 5A, lanes 6–13). Deletion of the glycine-
rich C-terminus, alone or in combination with RB1,
led to a striking increase in helicase activity (Figure 5A,
lanes 14–17, 5B, lanes 9–14), demonstrating that the
ssRNA-binding activity of the C-terminus is not required
for optimal unwinding, but conceivably for regulation
of the appropriate enzyme activity in a more physiological
context.
MLE functionsas amonomeric enzyme
For mechanistic considerations of helicase activity it is
important to establish whether MLE functions as a
monomeric or as a dimeric enzyme. It has previously
been suggested that monomeric helicases are characterized
by multiple RNA-binding domains (26), however, our
analysis shows that the predicted RB1 and the G-rich
C-terminusaredispensableforhelicaseactivity.Nativeand
recombinant RHA migrate as monomeric enzymes on
glycerol gradients (12,28). However, dimers may form
transiently and conditionally. For example, the HCV
helicase NS3 is a model for monomeric helicases (29,30),
yet an oligomeric state was evidenced by crosslinking and
has been suggested to be of functional importance (31). We
subjectedrecombinantfulllengthMLEtoglycerolgradient
sedimentation and observed a single peak of migration
around 140–160kDa (Figure 6A), which suggests that
MLE is predominantly monomeric in solution and
conﬁrms earlier results (11). Addition of various RNAs
(total cellular RNA, ss/ds EMSA probes) did not change
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956 Nucleic Acids Research, 2008, Vol. 36, No. 3this migration behavior. However, we cannot exclude that
dimerization might be promoted by a very speciﬁc RNA
substrate. In order to monitor more transient interactions
we coinfected Sf9 cells with viruses expressing His6-MLE
and various ﬂag-tagged MLE derivatives. We monitored
theexpressionofeachderivativebywesternblotanalysis of
total extracts from infected cells (Figure 6B, ‘input’). Flag-
tagged MLE derivatives were retrieved from the extracts
(Figure 6B, ‘pull down’, centre and bottom panel) and
probing for the his-tag revealed associated His6-MLE. This
experiment documented an interaction between two
diﬀerently tagged MLE proteins (Figure 6B, lane 8).
Deletion of RB1 did not aﬀect this interaction and deletion
of RB2 diminished the binding to some extent (Figure 6B,
lane 9). However, deleting the C-terminus (from aa 1163
onwards) abolished the interaction entirely (Figure 6B,
lane11). AC-terminalfragment containingthe glycine-rich
heptad repeats was able to pull down full length MLE very
eﬃciently (Figure 6B), which revealed a potential for this
peptide in MLE dimerization. However, MLE
G is a very
eﬃcient helicase in vitro (Figure 5), thus we conclude that
for mechanistic considerations MLE should be treated as a
monomeric helicase. A role for the glycine-rich C-terminus
in dimerization in a more physiological context cannot be
excluded.
Invivo localization
The association of MLE with the X chromosome in male
Drosophila cells depends on interactions with RNA, since
RNAse treatment of nuclei led to dissociation of MLE
(32). In order to see which of the RNA-binding domains
analyzed in this study were involved in X chromosome
targeting, we transiently expressed MLE derivatives
(Figure 2A) with C-terminal Green Fluorescent Protein
(GFP) fusions in male SF4 cells. Successful targeting to
the X chromosome was concluded from co-localization
with the MSL1 marker (Figure 7). For each fusion protein
at least 50 nuclei of MLE expressing cells were analyzed.
Clear and selective X chromosomal staining was scored as
positive (‘+’ in Figure 7B), whereas a clear enrichment of
GFP at sites of MSL1-binding over a diﬀuse nuclear
staining was scored as intermediate (‘+/ ‘in Figure 7B).
Examples are shown in Figure 7A. MLE-GFP fusion
protein localized to the X chromosomal territory with a
pattern very similar to endogenous MLE (data not
shown). 73% of all nuclei showed an enrichment of the
protein on the X chromosome. Inactivating the ATPase
activity of MLE (MLE
GET) led to a reduced X chromo-
somal targeting of the fusion protein. This is in agreement
with the observations of Lee et al. who found that
MLE
GET bound fewer sites on X chromosomes and an
B
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(11). Surprisingly, MLE
RB1 failed to be eﬃciently
targeted to the X chromosome. Considering that the
RNA-binding and helicase activities of this protein were
similar to wild type MLE, this suggests that RNA
interactions are not the only targeting principles.
However, RNA interactions are required for X chromo-
somal recognition, since deletion of RB2 abolished all
recruitment activity. MLE
G was found exclusively in the
cytoplasm. This may be explained by the fact that the
deletion removed a sequence preceding the G-rich heptad
repeats that harbors a candidate nuclear localization
sequence (NLS Supplementary Figure 2), which has
been recently mapped in the context of RHA (33,34).
We conﬁrmed the presence of an NLS in this fragment of
MLE by expression of the C-terminal fragment (‘G’ in
Figure 1) fused to GFP in SF4 cells (‘G’ in Figure 7). As
expected the fusion protein was nuclear, but did not
localize to the X chromosome. Lastly, we furnished the
MLE
G with a heterologous, SV40-derived NLS. The
fusion protein became nuclear by this NLS and localized
to the X chromosome with an intermediate eﬃciency,
similar to that of the MLE
GET mutant. In summary, this
experiment showed that the two N-terminal RB domains
contribute to X chromosome targeting. Targeting via RB2
may involve RNA interactions, since RB2 provides the
dominant RNA interaction surface. RB1, however, which
does not bind RNA, must contribute to targeting by other
types of interactions.
DISCUSSION
It is generally assumed that helicases make segments
of ss RNA available for interactors within complex
nucleoprotein assemblies. Little is known about the role
of MLE in dosage compensation, although the available
evidence suggests that its substrates are the long, non-
coding roX RNAs, which may need to be reorganized
for incorporation into productive DCCs. Whether
this reorganization involves unwinding inappropriate
secondary structures or destabilization of unwanted
protein–RNA interactions is unknown. A prerequisite to
understanding MLE’s function is knowledge about the
properties of its presumed RNA interaction domains,
which are predicted from sequence comparison, but have
not been characterized so far.
The role of theN-terminal dsRB motifs
The N-terminal RB1 and RB2 motifs of MLE are related
to a family of RNA-binding domains called dsRBM
dsRNA
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Figure 5. Contributions of MLE domains to helicase activity. Helicase reactions were carried out with increasing amounts (1.5, 3, 6, 12 fmole/75,
150, 300, 600pM) of MLE and derivatives and 25fmoles (1.25nM) of radiolabeled dsRNA as described in Materials and Methods section. Lanes 1
and 2 indicate the migration position of the ssRNA (boiled substrate) and dsRNA substrate, respectively. Lanes 3–5 correspond to unwinding
reactions from which ATP was omitted. In (B) diﬀerent enzyme preparations from the ones tested in (A) were used, with enzyme inputs of 6, 12, 25
fmoles.
958 Nucleic Acids Research, 2008, Vol. 36, No. 3(double-stranded RNA-binding motifs). Although the
name suggests that they interact with dsRNA it has
become clear that the term subsumes a variety of related
domains with diﬀerent interaction potential. This includes
ssRNA-binding and even protein interactions; for some
‘orphan dsRBMs’ interactors have not been identiﬁed so
far [(35) and references therein]. We now show that the
most N-terminal RBM of MLE (RB1), despite of its basic
nature, does not contribute to RNA-binding in vitro.A t
ﬁrst glance this ﬁnding is at odds with the observed RNA-
binding potential of the homologous domain in RHA (36).
However, a more resolving analysis revealed that dsRBM1
of RHA by itself is a poor RNA binder and requires the
context of a proline-rich segment between RHA aa 73–120
to bind nucleic acids, notably DNA in addition to RNA
(35). This accessory sequence is not conserved in MLE,
which explains the lack of RNA interaction in this
context. However, it remains possible that RB1 synergizes
with other structures within DCC to interact with nucleic
acids. Our observation that deletion of RB1 abolished the
targeting of MLE to the X chromosome territory in male
cells is consistent with this hypothesis. Whether this
targeting involves RNA, DNA or protein interactions
remains an interesting subject for future studies.
In striking contrast to the poor RNA interacting
potential of RB1, RB2 provides a dominant nucleic acid
input (1 %)  pull-down (3 %)
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Figure 6. Analysis of MLE dimerization. (A) Glycerol gradient sedimentation of MLE. 15mg of MLE was centrifuged through a 5–16% glycerol
gradient. 0.5ml fractions were collected. Aliquots (10ml) of each fraction were tested for the presence of MLE by western blotting using a speciﬁc
monoclonal antibody. The sedimentation positions of the molecular weight standards (catalase, 232kDa; aldolase, 158kDa) are indicated. The
bracket indicates MLE peak fractions. (B) MLE dimerization assessed by co-immunoprecipitation. His-tagged MLE was coexpressed in Sf9 cells with
ﬂag-tagged MLE derivatives in the combinations indicated. After ﬂag-mediated pull down from total Sf9 extracts, bound proteins were analyzed on a
8% or 15% SDS-PAGE (for the G-box domain) and western blot using anti-His (aHis) and anti-ﬂag (aﬂag) antibodies. An extract from Sf9 cells
expressing only His6-MLE served as a control (lane 7).
Nucleic Acids Research,2008, Vol. 36,No. 3 959interaction surface for MLE. Deletion of RB2 abolishes
those RNA interactions that resist the experimental
conditions of gel electrophoresis. Notably, RB2 is required
for RNA-dependent ATPase and helicase activity of MLE.
RB2–RNA interactions are therefore an obligatory inter-
mediate of MLE activity. Gibson and Thompson (26) have
speculated earlier on the importance of dsRB-type acces-
sory RNA interaction domains (i.e. those in addition to the
helicase domain) for helicase activity.
The role ofthe G-rich C-terminus
Our studies reveal integration of various functions at the
very C-terminus of MLE. This part of MLE is dominated
by a 9-fold imperfect repeat of the aa heptad GGGYGNN,
which is reminiscent of the wide spread RGG domains that
contribute to RNA-binding in many diﬀerent contexts.
This repeat is preceded by a basic sequence that is
conserved in vertebrate RHA, where it was shown to
function as an NLS (34). Although we have not repeated
the ﬁne mapping of the NLS in the context of MLE, our
data are consistent with the notion that the homologous
sequence (aa 1171–1189, Supplementary Figure 2) is
also an NLS. Deletion into this sequence (MLE
G)
destroys the nuclear localization of MLE and fusion of
the C-terminus targets GFP to the nucleus. There are other
examples where the NLS is separable from adjacent G-rich
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Figure 7. In vivo localization of MLE and MLE derivatives. (A) Drosophila SF4 cells were transiently transfected with either MLE or the indicated
MLE derivatives, all fused to GFP at the C-terminus. Localization of the fusion proteins was visualized by using anti-GFP antibodies (aGFP) and
the X territory was marked with anti-MSL1 antibodies (aMSL1). The DNA was counterstained with Hoechst 33258 (DNA). (B) Quantitative
analysis of the experiment. Clear and selective X chromosomal staining was scored as positive (‘+’), whereas a clear enrichment of GFP at sites of
MSL1-binding over a diﬀuse nuclear staining was scored as intermediate (‘+/ ’).
960 Nucleic Acids Research, 2008, Vol. 36, No. 3domains, such as the RGG/GAR domains (37). The basic
nature of the NLS may be responsible for the observed
RNA interactions in vitro. However, these interactions are
not required for helicase activity; to the contrary, deletion
of the entire C-terminus improves ssRNA interactions and
helicase activity of MLE in vitro. The C-terminus may thus
be engaged in other interactions, including transport
factors, and not be available for RNA-binding.
Interestingly, we observed that the C-terminus was able
to mediate MLE dimerization, which is reminiscent of the
glycine-rich GAR domains of hnRNPA1 that enable self-
association in vitro (38). The regular heptad repeat of a
tyrosyl residue may deﬁne a hydrophobic interaction
surface on a presumed amphipatic helix, which may
engage in corresponding interactions. These interactions
may play a regulatory role including conditional RNA-
binding. In the absence of these regulatory factors the C-
terminus may interact with RNA and retard helicase
activity, or interfere with ssRNA interactions of the
helicase domain. Interestingly, the GGGYGNN heptad is
not conserved even in the MLE of D.pseudoobscura and
D.virilis (Supplementary Figure 2), suggesting that
D.melanogaster MLE may have acquired a novel function.
The G-rich domain of vertebrtate RHA is reminiscent of
the well-known RGG/GAR domain found in many RNA-
binding proteins (26,38,39). RGG/GAR domains can
adopt a spiral structure through repeated b-turns and can
bind RNA non-speciﬁcally (40).
Implications forMLE function
The above considerations rest on the assumption that
MLE is a bona ﬁde helicase whose purpose is to unwind
double-stranded RNA. Such a scenario is consistent with
its role in para splicing (20). Conceivably, MLE modiﬁes
the secondary structures of the complex roX RNA to
facilitate the MSL protein interactions that characterize a
productive DCC. Currently it is not known whether DCC
corresponds to a single homogenous assembly or whether
variant conﬁgurations exist. Alternate RNA structures,
brought about by MLE action, may aﬀect the arrange-
ment and activity of the protein subunits of DCC.
Interestingly, certain RNA translocases are able to
displace bound protein by tracking along ssRNA, a
property that is ideally suited to (re-) organize the
conformations of ribonucleoprotein particles (41).
The context of DCC deﬁnes special circumstances of
MLE action. First, MLE must not necessarily be a very
processive enzyme in order to elicit its function. Further,
its action is likely to be sequence/structure-speciﬁc.
Identifying its preferred RNA substrate in the long roX
RNAs poses a considerable challenge. Finally, although
the association of MLE with the remaining DCC is
relatively labile, its co-localization with the other MSL
proteins on chromosomal target sites (1,42) suggests that
it is a component of DCC. How the context of the MSL
proteins aﬀect MLE functions remains to be explored.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
We thank F. Mu ¨ ller-Planitz for suggestions that improved
the manuscript, C. Schwarzlose for expert tissue culture
assistance, M. Kuroda for antibodies against MSL1
and the MLE cDNA. This work was supported by
Deutsche Forschungsgemeinschaft through Transregio 5
and Fonds der Chemischen Industrie. Funding to pay the
Open Access publication charges for this article was
provided by Deutsche Forschungsgemeinschaft.
Conﬂict of interest statement. None declared.
REFERENCES
1. Kuroda,M.I., Kernan,M.J., Kreber,R., Ganetzky,B. and Baker,B.S.
(1991) The maleless protein associates with the X chromosome to
regulate dosage compensation in Drosophila. Cell, 66, 935–947.
2. Deng,X. and Meller,V.H. (2006) Non-coding RNA in ﬂy dosage
compensation. Trends Biochem. Sci., 31, 526–532.
3. Straub,T. and Becker,P.B. (2007) Dosage compensation: the
beginning and end of generalisation. Nat. Rev. Genet., 8, 47–57.
4. Lucchesi,J.C., Kelly,W.G. and Panning,B. (2005) Chromatin
remodeling in dosage compensation. Annu. Rev. Genet., 39, 615–51.
5. Gilﬁllan,G.D., Straub,T., de Wit,E., Greil,F., Lamm,R., van
Steensel,B. and Becker,P.B. (2006) Chromosome-wide gene-speciﬁc
targeting of the Drosophila dosage compensation complex.
Genes Dev., 20, 858–870.
6. Alekseyenko,A.A., Larschan,E., Lai,W.R., Park,P.J. and
Kuroda,M.I. (2006) High-resolution ChIP-chip analysis reveals that
the Drosophila MSL complex selectively identiﬁes active genes on
the male X chromosome. Genes Dev., 20, 848–857.
7. Meller,V.H. and Rattner,B.P. (2002) The roX genes encode
redundant male-speciﬁc lethal transcripts required for targeting of
the MSL complex. EMBO J., 21, 1084–1091.
8. Akhtar,A., Zink,D. and Becker,P.B. (2000) Chromodomains are
protein-RNA interaction modules. Nature, 407, 405–409.
9. Morales,V., Regnard,C., Izzo,A., Vetter,I. and Becker,P.B. (2005)
The MRG domain mediates the functional integration of MSL3
into the dosage compensation complex. Mol. Cell Biol., 25,
5947–5954.
10. Buscaino,A., Kocher,T., Kind,J.H., Holz,H., Taipale,M.,
Wagner,K., Wilm,M. and Akhtar,A. (2003) MOF-regulated
acetylation of MSL-3 in the Drosophila dosage compensation
complex. Mol. Cell, 11, 1265–1277.
11. Lee,C.G., Chang,K.A., Kuroda,M.I. and Hurwitz,J. (1997) The
NTPase/helicase activities of Drosophila maleless, an essential
factor in dosage compensation. EMBO J., 16, 2671–2681.
12. Lee,C.G. and Hurwitz,J. (1993) Human RNA helicase A is
homologous to the maleless protein of Drosophila. J. Biol. Chem.,
268, 16822–16830.
13. Meller,V.H. (2003) Initiation of dosage compensation in Drosophila
embryos depends on expression of the roX RNAs. Mech. Dev., 120,
759–767.
14. Meller,V.H., Gordadze,P.R., Park,Y., Chu,X., Stuckenholz,C.,
Kelley,R.L. and Kuroda,M.I. (2000) Ordered assembly of roX
RNAs into MSL complexes on the dosage-compensated X
chromosome in Drosophila. Curr. Biol., 10, 136–143.
15. Gu,W., Wei,X., Pannuti,A. and Lucchesi,J.C. (2000) Targeting the
chromatin remodeling MSL complex of Drosophila to its sites of
action on the X chromosome requires both acetyl transferase and
ATPase activities. EMBO J., 19, 5202–5211.
16. Morra,R., Smith,E.R., Yokoyama,R. and Lucchesi,J.C. (2007) The
MLE subunit of the Drosophila MSL complex uses its ATPase
activity for dosage compensation and its helicase for targeting. Mol.
Cell Biol., Nov 26; [Epub ahead of print].
17. Deng,X., Rattner,B.P., Souter,S. and Meller,V.H. (2005) The
severity of roX1 mutations is predicted by MSL localization on the
X chromosome. Mech. Dev., 122, 1094–1105.
18. Mendjan,S., Taipale,M., Kind,J., Holz,H., Gebhardt,P.,
Schelder,M., Vermeulen,M., Buscaino,A., Duncan,K. et al. (2006)
Nuclear pore components are involved in the transcriptional
Nucleic Acids Research,2008, Vol. 36,No. 3 961regulation of dosage compensation in Drosophila. Mol. Cell, 21,
811–823.
19. Smith,E.R., Pannuti,A., Gu,W., Steurnagel,A., Cook,R.G.,
Allis,C.D. and Lucchesi,J.C. (2000) The drosophila MSL complex
acetylates histone H4at lysine 16, a chromatin modiﬁcation linked
to dosage compensation. Mol. Cell Biol., 20, 312–318.
20. Reenan,R.A., Hanrahan,C.J. and Barry,G. (2000) The mle(napts)
RNA helicase mutation in drosophila results in a splicing
catastrophe of the para Na+ channel transcript in a region of RNA
editing. Neuron, 25, 139–149.
21. Sanjuan,R. and Marin,I. (2001) Tracing the origin of the
compensasome: evolutionary history of DEAH helicase and MYST
acetyltransferase gene families. Mol. Biol. Evol., 18, 330–343.
22. Hartman,T.R., Qian,S., Bolinger,C., Fernandez,S.,
Schoenberg,D.R. and Boris-Lawrie,K. (2006) RNA helicase A is
necessary for translation of selected messenger RNAs. Nat. Struct.
Mol. Biol., 13, 509–516.
23. Robb,G.B. and Rana,T.M. (2007) RNA helicase A interacts with
RISC in human cells and functions in RISC loading. Mol. Cell, 26,
523–537.
24. Corona,D.F.V., La ¨ ngst,G., Clapier,C.R., Bonte,E.J., Ferrari,S.,
Tamkun,J.W. and Becker,P.B. (1999) ISWI is an ATP-dependent
nucleosome remodeling factor. Mol. Cell, 3, 239–245.
25. Morales,V., Straub,T., Neumann,M.F., Mengus,G., Akhtar,A. and
Becker,P.B. (2004) Functional integration of the histone acetyl-
transferase MOF into the dosage compensation complex. EMBO J.,
23, 2258–2268.
26. Gibson,T.J. and Thompson,J.D. (1994) Detection of dsRNA-
binding domains in RNA helicase A and Drosophila maleless:
implications for monomeric RNA helicases. Nucleic Acids Res., 22,
2552–2556.
27. Delagoutte,E. and von Hippel,P.H. (2002) Helicase mechanisms and
the coupling of helicases within macromolecular machines. Part I:
structures and properties of isolated helicases. Q. Rev. Biophys., 35,
431–478.
28. Lee,C.G. and Hurwitz,J. (1992) A new RNA helicase isolated from
HeLa cells that catalytically translocates in the 30 to 50 direction.
J. Biol. Chem., 267, 4398–4407.
29. Levin,M.K., Gurjar,M. and Patel,S.S. (2005) A Brownian motor
mechanism of translocation and strand separation by hepatitis C
virus helicase. Nat. Struct. Mol. Biol., 12, 429–435.
30. Dumont,S., Cheng,W., Serebrov,V., Beran,R.K., Tinoco,I. Jr,
Pyle,A.M. and Bustamante,C. (2006) RNA translocation and
unwinding mechanism of HCV NS3 helicase and its coordination by
ATP. Nature, 439, 105–108.
31. Levin,M.K. and Patel,S.S. (1999) The helicase from hepatitis C
virus is active as an oligomer. J. Biol. Chem., 274, 31839–31846.
32. Richter,L., Bone,J.R. and Kuroda,M.I. (1996) RNA-dependent
association of the Drosophila maleless protein with the male X
chromosome. Genes Cells, 1, 325–336.
33. Tang,H., McDonald,D., Middlesworth,T., Hope,T.J. and Wong-
Staal,F. (1999) The carboxyl terminus of RNA helicase A contains
a bidirectional nuclear transport domain. Mol. Cell Biol., 19,
3540–3550.
34. Aratani,S., Oishi,T., Fujita,H., Nakazawa,M., Fujii,R.,
Imamoto,N., Yoneda,Y., Fukamizu,A. and Nakajima,T. (2006) The
nuclear import of RNA helicase A is mediated by importin-alpha3.
Biochem. Biophys. Res. Commun., 340, 125–133.
35. Hung,M.L., Chao,P. and Chang,K.Y. (2003) dsRBM1 and a
proline-rich domain of RNA helicase A can form a composite
binder to recognize a speciﬁc dsDNA. Nucleic Acids Res., 31,
5741–5753.
36. Zhang,S. and Grosse,F. (1997) Domain structure of human nuclear
DNA helicase II (RNA helicase A). J. Biol. Chem., 272,
11487–11494.
37. Siomi,H. and Dreyfuss,G. (1995) A nuclear localization domain in
the hnRNP A1 protein. J. Cell Biol., 129, 551–560.
38. Ginisty,H., Sicard,H., Roger,B. and Bouvet,P. (1999) Structure and
functions of nucleolin. J. Cell Sci., 112(Pt 6), 761–772.
39. Kiledjian,M. and Dreyfuss,G. (1992) Primary structure and binding
activity of the hnRNP U protein: binding RNA through RGG box.
EMBO J., 11, 2655–2664.
40. Ghisolﬁ,L., Joseph,G., Amalric,F. and Erard,M. (1992) The glycine-
rich domain of nucleolin has an unusual supersecondary structure
responsible for its RNA-helix-destabilizing properties. J. Biol.
Chem., 267, 2955–2959.
41. Jankowsky,E. and Bowers,H. (2006) Remodeling of ribonucleo-
protein complexes with DExH/D RNA helicases. Nucleic Acids
Res., 34, 4181–4188.
42. Rastelli,L., Richman,R. and Kuroda,M.I. (1995) The dosage
compensation regulators MLE, MSL-1 and MSL-2 are interdepen-
dent since early embryogenesis in Drosophila. Mech. Dev., 53,
223–233.
962 Nucleic Acids Research, 2008, Vol. 36, No. 3